These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 32626768)
1. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population. Zahra MA; Kandeel M; Aldossary SA; Al-Taher A Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768 [TBL] [Abstract][Full Text] [Related]
2. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population. Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937 [TBL] [Abstract][Full Text] [Related]
3. Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers. Jarrar YB; Balasmeh AA; Jarrar W Libyan J Med; 2018 Dec; 13(1):1408381. PubMed ID: 29173142 [TBL] [Abstract][Full Text] [Related]
4. N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia. Kamel AM; Ebid GT; Moussa HS Tumour Biol; 2015 Aug; 36(8):6341-8. PubMed ID: 25804798 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Hein DW; Doll MA Pharmacogenomics; 2012 Jan; 13(1):31-41. PubMed ID: 22092036 [TBL] [Abstract][Full Text] [Related]
7. Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity. Njagi LN; Mecha JO; Mureithi MW; Otieno LE; Nduba V BMC Med Genomics; 2024 Jan; 17(1):14. PubMed ID: 38184575 [TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis. Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096 [TBL] [Abstract][Full Text] [Related]
10. Association of Walia HK; Singh N; Sharma S Pharmacogenomics; 2022 Jan; 23(2):97-118. PubMed ID: 34911343 [No Abstract] [Full Text] [Related]
11. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators. Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770 [TBL] [Abstract][Full Text] [Related]
12. Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine. Jorge-Nebert LF; Eichelbaum M; Griese EU; Inaba T; Arias TD Pharmacogenetics; 2002 Jan; 12(1):39-48. PubMed ID: 11773863 [TBL] [Abstract][Full Text] [Related]
14. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals. Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701 [TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 2 polymorphism and acetylation profiles in Buginese ethnics of Indonesia. Yuliwulandari R; Susilowati RW; Razari I; Viyati K; Umniyati H; Prayuni K Ann Hum Genet; 2019 Nov; 83(6):465-471. PubMed ID: 31332782 [TBL] [Abstract][Full Text] [Related]
16. [Identification of functionally significant mutations in NAT2 gene using biological microchips]. Kozhekbaeva ZhM; Glotov AS; Gra OA; Goldenkova-Pavlova IV; Bruskin SA; Agafonova EE; Markarova EV; Abdeev RM; Korsunskaia IM; Piruzian AL; Barskiĭ VE; Zasedatelev AS; Nasedkin TV Mol Biol (Mosk); 2007; 41(4):725-33. PubMed ID: 17936995 [TBL] [Abstract][Full Text] [Related]
17. Full-gene-sequencing analysis of N-acetyltransferase-2 in an adult Indian population. Tilak AV; Iyer SN; Mukherjee MS; Singhal RS; Lele SS Genet Test Mol Biomarkers; 2013 Mar; 17(3):188-94. PubMed ID: 23216273 [TBL] [Abstract][Full Text] [Related]
18. Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population. Salazar-González R; Gómez R; Romano-Moreno S; Medellín-Garibay S; Núñez-Ruíz A; Magaña-Aquino M; Milán-Segovia RC; Portales-Pérez DP Mol Biol Rep; 2014 Dec; 41(12):7833-43. PubMed ID: 25163630 [TBL] [Abstract][Full Text] [Related]
19. Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil. Teixeira RL; Miranda AB; Pacheco AG; Lopes MQ; Fonseca-Costa J; Rabahi MF; Melo HM; Kritski AL; Mello FC; Suffys PN; Santos AR Mutat Res; 2007 Nov; 624(1-2):31-40. PubMed ID: 17509624 [TBL] [Abstract][Full Text] [Related]
20. N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians. Aklillu E; Carrillo JA; Makonnen E; Bertilsson L; Djordjevic N Eur J Clin Pharmacol; 2018 Jul; 74(7):903-911. PubMed ID: 29589062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]